HAE

Haemonetics Corp

Sep 16 • 04:00PM ET

51.02

-0.33 -0.64 %

Healthcare • Medical Devices • USA • NYSE

Peers: ABT BDX BAX EW MDT HOLX STE BSX TFX XRAY

| Held by: VTI IJH IWM VB VBK VXF IWO MDY VTWO SCHA

Index	RUT	P/E	15.57	EPS (ttm)	3.28	Insider Own	1.39%	Shs Outstand	48.16M	Perf Week	-5.94%
Market Cap	2.46B	Forward P/E	9.30	EPS next Y	5.49	Insider Trans	0.00%	Shs Float	47.51M	Perf Month	-5.06%
Enterprise Value	3.39B	PEG	1.51	EPS next Q	1.11	Inst Own	113.27%	Short Float	7.72%	Perf Quarter	-27.07%
Income	163.34M	P/S	1.83	EPS this Y	5.59%	Inst Trans	0.21%	Short Ratio	4.14	Perf Half Y	-21.27%
Sales	1.35B	P/B	2.78	EPS next Y	13.74%	ROA	6.53%	Short Interest	3.67M	Perf YTD	-34.66%
Book/sh	18.32	P/C	8.39	EPS next 5Y	10.28%	ROE	18.27%	52W High	94.99 -46.29%	Perf Year	-30.36%
Cash/sh	6.08	P/FCF	12.99	EPS past 3/5Y	57.59% 17.48%	ROIC	9.06%	52W Low	50.68 0.67%	Perf 3Y	-33.63%
Dividend Est.	1.00 (1.96%)	EV/EBITDA	9.95	Sales past 3/5Y	11.07% 6.60%	Gross Margin	53.91%	Volatility	2.52% 2.46%	Perf 5Y	-45.48%
Dividend TTM	-	EV/Sales	2.52	EPS Y/Y TTM	45.81%	Oper. Margin	16.76%	ATR (14)	1.61	Perf 10Y	40.40%
Dividend Ex-Date	-	Quick Ratio	1.04	Sales Y/Y TTM	0.91%	Profit Margin	12.13%	RSI (14)	27.21	Recom	1.64
Dividend Gr. 3/5Y	- -	Current Ratio	1.72	EPS Q/Q	-5.43%	SMA20	-5.41%	Beta	0.38	Target Price	78.70
Payout	0.00%	Debt/Eq	1.39	Sales Q/Q	-4.40%	SMA50	-19.28%	Rel Volume	1.78	Prev Close	51.35
Employees	3023	LT Debt/Eq	1.04	Earnings	Aug 07 BMO	SMA200	-25.01%	Avg Volume	886.91K	Price	51.02
IPO	May 10, 1991	Option/Short	Yes / Yes	EPS/Sales Surpr.	9.11% 6.49%	Trades		Volume	1,578,043	Change	-0.64%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-11-25	Downgrade	Raymond James	Strong Buy → Outperform	$78
Aug-08-25	Reiterated	Barrington Research	Outperform	$95 → $86
Aug-08-25	Downgrade	JP Morgan	Overweight → Neutral	$62
Jul-09-25	Upgrade	Citigroup	Neutral → Buy	$90
Jun-26-25	Initiated	Robert W. Baird	Outperform	$87
Feb-07-25	Downgrade	BofA Securities	Neutral → Underperform	$95 → $68
Dec-06-24	Initiated	JP Morgan	Overweight	$116
Nov-08-24	Upgrade	Raymond James	Outperform → Strong Buy	$120
Sep-13-24	Initiated	CL King	Buy	$116
Sep-11-24	Initiated	BofA Securities	Neutral	$85
Sep-10-24	Initiated	BTIG Research	Buy	$112
Jun-12-24	Upgrade	Needham	Hold → Buy	$112
Oct-13-22	Initiated	Mizuho	Buy	$90
Jan-27-22	Downgrade	Needham	Buy → Hold
Dec-15-21	Downgrade	Citigroup	Buy → Neutral	$75 → $59
Aug-17-21	Resumed	Raymond James	Outperform	$75
Jun-17-21	Initiated	Citigroup	Buy	$75
May-14-21	Upgrade	CJS Securities	Market Perform → Market Outperform
Apr-20-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-19-21	Downgrade	CJS Securities	Market Outperform → Market Perform

Show Previous Ratings

Aug-23-25 04:00AM	Mizuho Reduces PT on Haemonetics Corporation (HAE) Following Fiscal Q1 2025 Results (Insider Monkey)
Aug-14-25 01:41AM	The Top 5 Analyst Questions From Haemonetics's Q2 Earnings Call (StockStory)
Aug-11-25 09:38AM	HAE Q2 Deep Dive: Margin Expansion Amid Revenue Decline and Product Execution Challenges (StockStory)
09:33AM	Arm initiated, Adobe downgraded: Wall Street's top analyst calls (The Fly)
09:15AM	Understanding Haemonetics (HAE) Reliance on International Revenue (Zacks)
02:08PM	Loading…
Aug-07-25 02:08PM	Haemonetics (NYSE:HAE) Surprises With Strong Q2 But Stock Drops 24% (StockStory) -26.58%
09:30AM	Haemonetics (HAE) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
07:10AM	Haemonetics (HAE) Q1 Earnings and Revenues Surpass Estimates (Zacks)
06:07AM	Haemonetics: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
06:00AM	Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website (PR Newswire)
Aug-06-25 09:15AM	Unlocking Q1 Potential of Haemonetics (HAE): Exploring Wall Street Estimates for Key Metrics (Zacks)
Aug-05-25 11:18PM	Haemonetics (HAE) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Jul-31-25 10:00AM	Analysts Estimate Haemonetics (HAE) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jul-27-25 10:01AM	Haemonetics Builds Momentum with New Buy Rating and Growth Promise (Insider Monkey)
Jul-23-25 07:40AM	Boston Scientific (BSX) Q2 Earnings and Revenues Surpass Estimates (Zacks)
04:52PM	Loading…
Jul-10-25 04:52PM	Integer Appoints Michael Coyle to Board of Directors (GlobeNewswire)
Jul-09-25 11:38PM	Unpacking Q1 Earnings: Haemonetics (NYSE:HAE) In The Context Of Other Medical Devices & Supplies - Specialty Stocks (StockStory)
04:05PM	Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025 (PR Newswire)
10:28AM	Citi adjusts MedTech outlook: Bullish on Haemonetics, bearish on Tandem Diabetes (Investing.com)
Jun-27-25 05:44AM	5 Must-Read Analyst Questions From Haemonetics's Q1 Earnings Call (StockStory)
Jun-05-25 07:56AM	HAE Q1 Earnings Call: Revenue Misses Expectations, Margin Expansion and Product Focus Highlighted (StockStory)
May-30-25 06:00AM	Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference (PR Newswire)
May-12-25 08:40AM	HAE Stock Gains on Q4 Earnings and Revenue Beat, Margins Up (Zacks)
May-09-25 08:30PM	Here's What Key Metrics Tell Us About Haemonetics (HAE) Q4 Earnings (Zacks)
03:08AM	Haemonetics Corp (HAE) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... (GuruFocus.com)
12:35AM	1 Healthcare Stock to Consider Right Now and 2 to Brush Off (StockStory)
May-08-25 09:20AM	Haemonetics (HAE) Q4 Earnings and Revenues Surpass Estimates (Zacks) +5.85%
08:19AM	Haemonetics: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
06:00AM	Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website (PR Newswire)
May-07-25 06:10PM	QuidelOrtho (QDEL) Q1 Earnings and Revenues Top Estimates (Zacks)
06:00PM	Loading…
06:00PM	Here are the major earnings before the open tomorrow (Seeking Alpha)
12:00PM	Haemonetics Q4 2025 Earnings Preview (Seeking Alpha)
09:55AM	Earnings To Watch: Haemonetics Corp (HAE) Reports Q4 2025 Result (GuruFocus.com)
09:15AM	Gear Up for Haemonetics (HAE) Q4 Earnings: Wall Street Estimates for Key Metrics (Zacks)
May-01-25 10:01AM	Haemonetics (HAE) Earnings Expected to Grow: Should You Buy? (Zacks)
07:27AM	4 MedTech Stocks Poised to Outshine Q1 Earnings Estimates (Zacks)
Apr-27-25 01:13PM	1 Profitable Stock Worth Your Attention and 2 to Question (StockStory)
Apr-23-25 07:46AM	Vivasure wins CE mark for bioresorbable PerQseal Elite device (Medical Device Network)
Apr-11-25 12:55PM	Is Haemonetics Corporation (HAE) the Best Russell 2000 Stock to Buy According to Wall Street Analysts? (Insider Monkey)
Apr-04-25 05:03AM	Q4 Earnings Highs And Lows: Haemonetics (NYSE:HAE) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks (StockStory)
Apr-02-25 05:06AM	3 Reasons to Avoid HAE and 1 Stock to Buy Instead (StockStory)
Apr-01-25 08:43AM	Haemonetics Corp. (HAE): Among the 10 Pro-Life Companies to Invest In Now? (Insider Monkey)
Mar-31-25 04:00PM	Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025 (PR Newswire)
Mar-27-25 10:35PM	Royce Small-Cap Fund Q4 2024 Commentary (SeekingAlpha)
Mar-20-25 11:30AM	Medtronic (MDT) Up 5.6% Since Last Earnings Report: Can It Continue? (Zacks)
09:03AM	3 Healthcare Stocks Walking a Fine Line (StockStory)
Mar-11-25 05:04AM	Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers (StockStory)
Mar-03-25 04:10PM	Haemonetics Announces Executive Leadership Updates (PR Newswire)
Feb-28-25 04:03AM	A Look Back at Medical Devices & Supplies - Specialty Stocks Q3 Earnings: STAAR Surgical (NASDAQ:STAA) Vs The Rest Of The Pack (StockStory)
Feb-24-25 06:00AM	Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference (PR Newswire)
Feb-09-25 08:02AM	Inspire Medical Systems (INSP) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Feb-07-25 02:07AM	Haemonetics Corp (HAE) Q3 2025 Earnings Call Highlights: Strong Hospital Growth Amid Plasma ... (GuruFocus.com) -5.79%
Feb-06-25 09:30AM	Haemonetics (HAE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -11.58%
07:40AM	Haemonetics (HAE) Q3 Earnings Meet Estimates (Zacks)
06:39AM	Haemonetics: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
06:37AM	Haemonetics Narrows FY25 Adj. EPS Outlook Range, But Trims Revenue Growth - Update (RTT News)
06:28AM	Haemonetics (NYSE:HAE) Misses Q4 Revenue Estimates (StockStory)
06:00AM	Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website (PR Newswire)
Feb-05-25 08:03AM	Earnings To Watch: Haemonetics (HAE) Reports Q4 Results Tomorrow (StockStory)
07:07AM	Haemonetics Corp (HAE) Q3 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Jan-24-25 09:40AM	Here's Why Haemonetics (HAE) is a Strong Value Stock (Zacks)
Jan-14-25 06:13AM	Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A (PR Newswire)
Jan-08-25 05:03PM	Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025 (PR Newswire)
09:40AM	Why Haemonetics (HAE) is a Top Value Stock for the Long-Term (Zacks)
Jan-06-25 06:00AM	Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-23-24 09:35AM	Down -11.82% in 4 Weeks, Here's Why You Should You Buy the Dip in Haemonetics (HAE) (Zacks)
Dec-06-24 09:40AM	Are Investors Undervaluing Haemonetics (HAE) Right Now? (Zacks)
Dec-04-24 09:55AM	Wall Street Analysts See a 27.84% Upside in Haemonetics (HAE): Can the Stock Really Move This High? (Zacks)
06:22AM	Haemonetics to offload whole-blood business for up to $67M (MedTech Dive)
Dec-03-24 01:16AM	Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A (PR Newswire)
Nov-14-24 05:35AM	Haemonetics to close California facility, lay off 75 people (MedTech Dive)
Nov-12-24 04:12PM	Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update (GlobeNewswire)
09:40AM	Here's Why Haemonetics (HAE) is a Strong Value Stock (Zacks)
Nov-11-24 09:55AM	Wall Street Analysts Think Haemonetics (HAE) Could Surge 25.58%: Read This Before Placing a Bet (Zacks)
Nov-07-24 09:30AM	Compared to Estimates, Haemonetics (HAE) Q2 Earnings: A Look at Key Metrics (Zacks) +10.71%
07:25AM	Haemonetics (HAE) Tops Q2 Earnings and Revenue Estimates (Zacks)
06:26AM	Haemonetics: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website (PR Newswire)
Nov-06-24 09:15AM	Haemonetics (HAE) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
07:09AM	Haemonetics Corp (HAE) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-31-24 10:01AM	Haemonetics (HAE) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-09-24 05:28PM	Haemonetics Corp (HAE) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
Oct-03-24 04:05PM	Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024 (PR Newswire)
Sep-24-24 08:00AM	Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer (GlobeNewswire)
Sep-20-24 12:54AM	Is Haemonetics Corporation (HAE) an Undervalued Healthcare Stock to Buy in 2025 (Insider Monkey)
Sep-02-24 09:35AM	After Plunging -15.88% in 4 Weeks, Here's Why the Trend Might Reverse for Haemonetics (HAE) (Zacks)
Aug-23-24 09:22AM	Implied Volatility Surging for Haemonetics (HAE) Stock Options (Zacks)
Aug-16-24 09:08AM	Haemonetics (HAE) Set to Launch VASCADE MVP XL in US (Zacks)
06:33AM	Haemonetics Vascade MVP XL vascular closure system enters US market (Medical Device Network)
Aug-15-24 06:30AM	Haemonetics Announces Full Market Release for VASCADE MVP XL Vascular Closure System (PR Newswire)
Aug-12-24 07:47AM	Haemonetics (HAE) Q1 Earnings Miss Estimates, Gross Margin Rises (Zacks)
Aug-09-24 09:40AM	Is Haemonetics (HAE) Stock Undervalued Right Now? (Zacks)
09:35AM	Down -14.6% in 4 Weeks, Here's Why Haemonetics (HAE) Looks Ripe for a Turnaround (Zacks)
Aug-08-24 07:25AM	Haemonetics (HAE) Misses Q1 Earnings Estimates (Zacks) -10.84%
06:25AM	Haemonetics: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
06:00AM	Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website (PR Newswire)
Aug-07-24 09:55AM	Wall Street Analysts See a 30.13% Upside in Haemonetics (HAE): Can the Stock Really Move This High? (Zacks)
09:40AM	Why Haemonetics (HAE) is a Top Value Stock for the Long-Term (Zacks)
Aug-01-24 07:00AM	Sotera Health Appoints Christopher Simon to the Board of Directors (GlobeNewswire)
Jul-30-24 06:00AM	Haemonetics Announces CE Mark Certification for the SavvyWire Pre-Shaped Pressure Guidewire (PR Newswire)

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
Llorens Josep	Former Officer	Jun 26 '25	Proposed Sale	74.94	18,630	1,396,132	Jun 26 10:49 AM
Strong Stewart W	Former Officer	Jun 12 '25	Proposed Sale	71.46	708	50,593	Jun 12 04:51 PM
Strong Stewart W	Officer	Jun 04 '25	Proposed Sale	69.90	7,705	538,580	Jun 04 10:06 AM
Strong Stewart W	Officer	Jun 02 '25	Proposed Sale	67.47	2,835	191,277	Jun 02 01:16 PM
Llorens Josep	Officer	May 19 '25	Proposed Sale	69.37	1,547	107,319	May 19 04:12 PM
Lingamneni Anila	Former Officer	Nov 11 '24	Proposed Sale	90.68	6,238	565,692	Nov 12 11:26 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HAE

Haemonetics Corp

Upgrade your FINVIZ experience